(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADXPROSTATE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ADXPROSTATE

ST13

US500000079221126

Class

5, 10

Filing

79221126

Registration

5489002

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

03/06/2026

Trademark type

Word

Nice classes

5, 10

Filing date

09/27/2017

Registration date

06/12/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/27/2024

Last transaction

03/06/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Sunderland SR5 2TA, GB

Examiner

RINKER, ANTHONY MICHAEL

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Arquer Diagnostics Limited

Representatives

Lisa A. Dunner Dunner Law PLLC

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for medical use for detecting cancer; diagnostic agents for medical use for detecting cancer; diagnostic re-agents for medical use for detecting cancer; diagnostic biomarkers for medical use for detecting cancer

Class 10

Medical diagnosis apparatus and equipment for detecting cancer; medical screening apparatus and equipment for detecting cancer; parts and fittings for the aforesaid goods

Publications

History of USPTO decisions and trademark events.

28 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

03/05/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/13/2026

INPC

INVALIDATION PROCESSED

02/13/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

08/27/2025

C71T

CANCELLED SECTION 71

12/27/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/12/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/09/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/06/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/18/2018

FIMP

FINAL DISPOSITION PROCESSED

09/18/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/12/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

06/12/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/27/2018

PUBO

PUBLISHED FOR OPPOSITION

03/27/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/07/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/22/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/21/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/21/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/21/2018

RFNP

REFUSAL PROCESSED BY IB

02/03/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/17/2018

RFRR

REFUSAL PROCESSED BY MPU

01/17/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/04/2018

CNRT

NON-FINAL ACTION WRITTEN

01/03/2018

DOCK

ASSIGNED TO EXAMINER

01/03/2018

MAFR

APPLICATION FILING RECEIPT MAILED

11/29/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/25/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/16/2017

Continuous trademark protection

Get notified about every new filing that threatens ADXPROSTATE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.